|
MedChemExpress
anti sall4 Anti Sall4, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sall4/SALL4+Antibody/pmc11880302-75-7-24 Average 93 stars, based on 1 article reviews
anti sall4 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
sall4 Sall4, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sall4/Sall4+Antibody/10__1016_slash_j__jia__2025__07__024-94-21-23 Average 93 stars, based on 1 article reviews
sall4 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
OriGene
hgc 27 cells Hgc 27 Cells, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sall4/SALL4+(NM_020436)+Human+Tagged+ORF+Clone/pm24276240-165-20-36 Average 90 stars, based on 1 article reviews
hgc 27 cells - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
anti sall4 Anti Sall4, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sall4/Sall4+Antibody/pmc05915399-149-22-25 Average 93 stars, based on 1 article reviews
anti sall4 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Addgene inc
sall4 ![]() Sall4, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sall4/FUW-TetO-Zeo-Sall4+(Plasmid+%2340797)/pmc04347641-99-31-50 Average 90 stars, based on 1 article reviews
sall4 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Proteintech
anti sall4 ![]() Anti Sall4, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sall4/SALL4+Antibody/pmc07739211-61-4-6 Average 92 stars, based on 1 article reviews
anti sall4 - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
sall4 hdr plasmid h ![]() Sall4 Hdr Plasmid H, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sall4/Sall4+HDR+Plasmid/pm37525212-61-2-7 Average 91 stars, based on 1 article reviews
sall4 hdr plasmid h - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
sall4 rabbit monoclonal antibody ![]() Sall4 Rabbit Monoclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sall4/Sall4+Rabbit+mAb/pmc08769893-172-11-15 Average 93 stars, based on 1 article reviews
sall4 rabbit monoclonal antibody - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
sall4 sirna ![]() Sall4 Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sall4/Sall4+siRNA/pmc04694999-164-1-3 Average 93 stars, based on 1 article reviews
sall4 sirna - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Novus Biologicals
sall4 ![]() Sall4, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sall4/SALL4+Antibody+(SALL4%2F7301R)/pm28954928-257-47-64 Average 90 stars, based on 1 article reviews
sall4 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Cyagen Biosciences
sall4 ![]() Sall4, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sall4/Sall4/pm24276240-179-10-58 Average 90 stars, based on 1 article reviews
sall4 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
OriGene
sall4 ![]() Sall4, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sall4/Sall4+Goat+Polyclonal+Antibody/pmc09721057-12-0-9 Average 90 stars, based on 1 article reviews
sall4 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: The Journal of Cell Biology
Article Title: Stemness factor Sall4 is required for DNA damage response in embryonic stem cells
doi: 10.1083/jcb.201408106
Figure Lengend Snippet: Sall4 −/− ESCs are impaired in ATM activation and hypersensitive to DOX treatment. (A) Phosphorylation of ATM, H2AX, and p53 in Sall4 +/− and Sall4 −/− ESCs at different time points after DOX treatment. (B and C) Sall4 +/− and Sall4 −/− ESCs were mixed, treated with DOX or mock treated, and examined for the foci formation by ATM-Ser1987p (B) or γ-H2AX (C). DNA is counterstained with DAPI (blue). Bars, 10 µm. Graphs show the change of average fluorescence intensity (AFI) determined by dividing the overall mean fluorescence intensity by the area of the cell, and values are mean ± SEM. **, P < 0.01; ***, P < 0.001 by t test throughout the figure. (D) Cell cycle G 2 /M checkpoint is impaired in Sall4 −/− ESCs after DOX treatment. (top) Mock-treated control. (bottom) 1 h after after DOX treatment. The values are means ± SEM ( n = 4). *, P < 0.05 by t test. Circles denote the percentages of cells positive for histone 3 phosphorylated at Ser10 in all cells. PI-A, propidium iodide area. (E) Inducible expression of Sall4 in Sall4 −/− ESCs rescues the activation of ATM after DOX (0.5 µM) treatment. Sall4 −/− ESCs were stably transfected with a doxycycline-inducible vector expressing ectopic Sall4 (Lenti- Sall4 ).
Article Snippet: All of lentivirus packaging plasmid (psPAX2, plasmid #12260, CAG promoter), envelope plasmid (pMD2.G, plasmid #12259, cytomegalovirus [CMV] promoter), the reverse tetracycline transactivator (FUW-M2rtTA, plasmid #20342, CMV promoter), and lentiviral vectors containing
Techniques: Activation Assay, Phospho-proteomics, Fluorescence, Control, Expressing, Stable Transfection, Transfection, Plasmid Preparation
Journal: The Journal of Cell Biology
Article Title: Stemness factor Sall4 is required for DNA damage response in embryonic stem cells
doi: 10.1083/jcb.201408106
Figure Lengend Snippet: Sall4 is relocated from the heterochromatin to DNA DSBs in ESCs after DOX treatment. (A) Sall4 is sequestered in the heterochromatin and relocated to DNA DSBs in ESCs after DNA damage. Sall4 +/− cells were examined for the foci formation of γ-H2AX and Sall4 before and after DNA DSB damage induced by DOX. Nuclei were counterstained with DAPI (blue). For intensity correlation analysis (ICA), pixels from the Sall4 channel covarying positively with the corresponding signal from the γ-H2AX or DAPI channel are denoted. Bar, 5 µm. (B) Rr analysis for the colocalization of Sall4 and γ-H2AX. Rr is the Pearson’s correlation coefficient, and a value of 1 indicates perfect colocalization. The values of Rr are means ± SEM. ***, P < 0.001 by t test. (C) Sall4 is colocalized with HP1-α foci before DNA DSB damage and is mobilized out of HP1-α foci after DNA damage. Nuclei are counterstained with DAPI (blue). Bar, 5 µm. (D) The average fluorescence intensity (AFI) of Sall4 at heterochromatin was determined by dividing the overall mean fluorescence intensity by the area of the cell, and values are means ± SEM. **, P < 0.01 by t test. (E) DNA damage disrupts the interaction between Sall4 and HP1-α in ESCs. The interaction between Sall4 and HP1-α was analyzed by coimmunoprecipitation (Co-IP) with the HP1-α antibody.
Article Snippet: All of lentivirus packaging plasmid (psPAX2, plasmid #12260, CAG promoter), envelope plasmid (pMD2.G, plasmid #12259, cytomegalovirus [CMV] promoter), the reverse tetracycline transactivator (FUW-M2rtTA, plasmid #20342, CMV promoter), and lentiviral vectors containing
Techniques: Fluorescence, Co-Immunoprecipitation Assay
Journal: The Journal of Cell Biology
Article Title: Stemness factor Sall4 is required for DNA damage response in embryonic stem cells
doi: 10.1083/jcb.201408106
Figure Lengend Snippet: Sall4 and Baf60a are required for recruiting or stabilizing MRN complex at sites of DNA DSBs. (A) Schematic overview of mass spectrometric analysis for proteins interacting with Sall4 in ESCs. (B) The interaction between Sall4 and Rad50 or Sall4 and Baf60a was confirmed by coimmunoprecipitation (Co-IP). The samples were immunoprecipitated with the anti-Sall4 antibody, and the levels of proteins in the immunoprecipitation or input were determined by Western blotting. (C) The association of various proteins with DNA DSBs in Sall4 +/− and Sall4 −/− ESCs treated with 0.5 µM DOX for 4 h was determined by the linear dsDNA pull-down assay. The levels of proteins in the input whole nuclear extract (WNE) and DSB pull-down were determined by Western blotting. Short (left) and long (right) exposure of the same blots are shown. (D) Silencing of Baf60a reduces the association of Sall4, Rad50, and ATM with DNA DSBs in ESCs treated with DOX. The protein levels of Sall4, Rad50, and ATM in the whole nuclear extract input and the linear dsDNA pull-down were determined by Western blotting. (E) Silencing of Baf60a impairs the ATM activation in ESCs after DOX treatment. (F) Nuclear (Nu) and cytoplasmic (Cyto) distribution of Rad50 and Baf60a in Sall4 +/− and Sall4 −/− ESCs treated with 0.5 µM DOX for 4 h. si-Con, control siRNA.
Article Snippet: All of lentivirus packaging plasmid (psPAX2, plasmid #12260, CAG promoter), envelope plasmid (pMD2.G, plasmid #12259, cytomegalovirus [CMV] promoter), the reverse tetracycline transactivator (FUW-M2rtTA, plasmid #20342, CMV promoter), and lentiviral vectors containing
Techniques: Co-Immunoprecipitation Assay, Immunoprecipitation, Western Blot, Pull Down Assay, Activation Assay, Control
Journal: The Journal of Cell Biology
Article Title: Stemness factor Sall4 is required for DNA damage response in embryonic stem cells
doi: 10.1083/jcb.201408106
Figure Lengend Snippet: Sall4 linking SWI/SNF-associated chromatin remodeling to MRN-dependent ATM activation. (A) Silencing of Baf60a impairs the recruitment of Sall4 to γ-H2AX foci after DNA DSB damage. Nuclei are counterstained with DAPI (blue). For intensity correlation analysis (ICA), pixels from the Sall4 channel covarying positively with the corresponding signal from the γ-H2AX channel are denoted. si-Con, control siRNA. Bar, 5 µm. (B) Inhibition of H3K14ac by CPTH2 disrupts the association of Baf60a, Sall4, and ATM with DNA DSBs in the cellular extract of Sall4 +/− ESCs treated with 0.5 µM DOX for 4 h. WNE, whole nuclear extract. (C) Inhibition of H3K14ac by CPTH2 in Sall4 +/− ESCs impaired ATM-dependent responses to DNA DSB damage. (D) The kinetics of the recruitment of Rad50, Sall4, and Balf60a to the specific DNA DSB. ChIP analysis showed the kinetics of the recruitment of Sall4, Rad50, and Baf60a to the single I-PpoI cleavage site at chromosome 3 in Sall4 +/− cells. Time denotes the minutes after the addition of 4-hydroxytamoxifen. Values are means ± SEM. (E) An illustrated model for Sall4 to function as a transducer of chromatin remodeling to ATM signaling in ESCs after DNA damage. P, phosphorylation.
Article Snippet: All of lentivirus packaging plasmid (psPAX2, plasmid #12260, CAG promoter), envelope plasmid (pMD2.G, plasmid #12259, cytomegalovirus [CMV] promoter), the reverse tetracycline transactivator (FUW-M2rtTA, plasmid #20342, CMV promoter), and lentiviral vectors containing
Techniques: Activation Assay, Control, Inhibition, Phospho-proteomics
Journal: Cancer cell international
Article Title: SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression.
doi: 10.1186/s12935-023-02985-9
Figure Lengend Snippet: Fig. 1 Upregulated SALL4 in STAD promotes tumor progression and indicates a poor prognosis, according to the TCGA database. A, B Kaplan-Meier analysis of overall survival in STAD patients based on SALL4 expression; C Overall survival analysis for the overall survival of STAD patients via Kaplan- Meier plotter. Data were acquired from the TCGA dataset via https://portal.gdc.cancer.gov, https://www.cbioportal.org/, and http://kmplot.com/analysis/ database and analyzed by IBM SPSS Statistics 23 software. Spearman correlation analysis of SALL4 mRNA expression with the transcripts of angiogenesis- associated genes. D-F Scatter plots depicting the significant correlation between SALL4 expression and the mRNA levels of VEGF-A (D), VEGF-B (E), and VEGF-C (F) mRNA expression levels in 367 STAD patients from the TCGA database. Data were acquired from the TCGA dataset via the https://portal.gdc. cancer.gov database and analyzed by IBM SPSS Statistics 23 software. The results are presented as the means ± standard error of mean (SEM). *P < 0.05, **P < 0.01, and ***P < 0.001
Article Snippet: Co-transfection with
Techniques: Expressing, Software
Journal: Cancer cell international
Article Title: SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression.
doi: 10.1186/s12935-023-02985-9
Figure Lengend Snippet: Fig. 2 SALL4 regulates VEGF-A, B, and C expression levels. SALL4-B downregulation by siRNA decreases, while upregulation by over-expressing plasmid (P-SALL4-B) increases the expression levels of VEGF-A, B, and C in MKN-45, MGC-803, and HGC-27 cells. A-D qRT-PCR analysis of SALL4-B, VEGF-A, B, and C mRNA expression levels in MKN-45, MGC-803, and HGC-27 cells. E-H Western blot analyses for protein levels of SALL4-B, VEGF-A, VEGF-B, and VEGF-C in MKN-45, MGC-803, and HGC-27. GAPDH was used as a loading control. I-L The expression level of VEGF-A, B, and C in the CM from MKN-45, MGC-803, and HGC-27-si-NC/si-SALL4-B and Vector/ P-SALL4-B cells were detected by ELISA assay. The results are presented as the means ± standard error of mean (SEM). *P < 0.05, **P < 0.01, and ***P < 0.001
Article Snippet: Co-transfection with
Techniques: Expressing, Plasmid Preparation, Quantitative RT-PCR, Western Blot, Control, Enzyme-linked Immunosorbent Assay
Journal: Cancer cell international
Article Title: SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression.
doi: 10.1186/s12935-023-02985-9
Figure Lengend Snippet: Fig. 3 SALL4 regulates angiogenesisin vitro. A-D CCK-8 assays were used to assess cell proliferation after a 48-hour treatment. E-H Transwell migration assays were performed on HUVECs treated with CM from si-Ctrl/si-SALL4-B or Vector/P-SALL4-B gastric cancer cells. I-L Tube formation assays in si-Ctrl/ si-SALL4-B or Vector/P-SALL4-B CM-treated HUVECs. The results are presented as the means ± standard error of mean (SEM). **P < 0.01, and ***P < 0.001
Article Snippet: Co-transfection with
Techniques: CCK-8 Assay, Migration, Plasmid Preparation
Journal: Cancer cell international
Article Title: SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression.
doi: 10.1186/s12935-023-02985-9
Figure Lengend Snippet: Fig. 4 SALL4 binds to VEGF-A, B, and C gene promoter and activate their expression. A-F ChIP was used to examine the association of SALL4, Di-methyl ation (H3-K79), or Tri-methylation (H3-K4) with the VEGF-A, B, or C promoters in MGC-803 cells. Briefly, qRT-PCR was used to amplify SALL4, Di-methylation (H3-K79), or Tri-methylation (H3-K4) immunoprecipitated DNA using specific primers. As indicated, total input was used as a positive control. G-I. EMSA assay was used to determine the binding of VEGF-A, B, or C probes to nuclear extract protein (P-SALL4). To this end, Lane 1 contains DNA markers. Lane 2 contains only VEGF-A, B, or C probe (100 ng). Lanes 3–7: 100 ng aliquots of VEGF-A, B, or C probe with increasing amounts of nuclear extract protein (P-SALL4) (3,5,7,9,11 ug). SYBR Green EMSA stain was used to stain the gel in panel A (Green). Panel B shows the same gel stained with SYPRO Ruby EMSA stain (Red). The arrow points to the VEGF-A, B, or C probe-nuclear extract protein (P-SALL4) complex, which is stained in both panels (Yellow). (Additional file 2) shows the sequences of the putative SALL4-binding site. The results are presented as the means ± standard error of mean (SEM). *P < 0.05, *** P < 0.001
Article Snippet: Co-transfection with
Techniques: Expressing, Methylation, Quantitative RT-PCR, Immunoprecipitation, Positive Control, Binding Assay, SYBR Green Assay, Staining
Journal: Cancer cell international
Article Title: SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression.
doi: 10.1186/s12935-023-02985-9
Figure Lengend Snippet: Fig. 5 Knockout of SALL4 by CRISPR/Cas9 inhibits the pro-angiogenic effect of gastric cancer cellsin vitro. A Immunofluorescence and western blot analysis were used for the confirmation of the CRISPR/Cas9 knockout experiment. B The expression levels of SALL4-B, VEGF-A, B, and C mRNA were determined by qRT-PCR in gastric cancer cells with SALL4 knockout by CRISPR/Cas9. C The expression levels of SALL4-B, VEGF-A, B, and C proteins were determined by western blot in gastric cancer cells with SALL4 knockout by CRISPR/Cas9. GAPDH was used as a loading control. D The expression level of VEGF-A, B, and C in the CM from control and SALL4 knockout cells were detected by ELISA assay. HUVECs were treated with a serum-free medium or CMs from SALL4 knockout gastric cancer cells. E After treatment for 48 h, CCK-8 assays were performed to evaluate cell proliferation. F Transwell migration assay was performed to determine the migration of HUVECs with CM treatment. G Tube formation in HUVECs treated with indicated CMs. The results are presented as the means ± standard error of mean (SEM). ***P < 0.001
Article Snippet: Co-transfection with
Techniques: Knock-Out, CRISPR, Immunofluorescence, Western Blot, Expressing, Quantitative RT-PCR, Control, Enzyme-linked Immunosorbent Assay, CCK-8 Assay, Transwell Migration Assay, Migration
Journal: Cancer cell international
Article Title: SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression.
doi: 10.1186/s12935-023-02985-9
Figure Lengend Snippet: Fig. 6 Thalidomide decreases SALL4 expression and inhibits angiogenesis. A SALL4-B, VEGF-A, B, and C expression levels were measured in MGC-803 cells treated with different concentrations of Thalidomide by using real-time qRT-PCR. B SALL4-B, VEGF-A, B, and C protein expression levels were deter mined by using western blots in MGC-803 cells treated with different concentrations of Thalidomide. C ELISA assay was used to measure VEGF-A, B, and C expression levels in a conditioned medium (CM) from MGC-803 cells. D CCK-8 assay was used to assess HUVEC cell proliferation after treatment with CM from MGC-803 cells. E Transwell assay was used to examine the effects of CM from MGC-803 cells on the migration of HUVEC cells. F Tube formation of HUVECs after treatment with CM from MGC-803 cells. The results are presented as the means ± standard error of mean (SEM) **P < 0.01, and ***P < 0.001
Article Snippet: Co-transfection with
Techniques: Expressing, Quantitative RT-PCR, Western Blot, Enzyme-linked Immunosorbent Assay, CCK-8 Assay, Transwell Assay, Migration
Journal: Cancer cell international
Article Title: SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression.
doi: 10.1186/s12935-023-02985-9
Figure Lengend Snippet: Fig. 8 Exosomes deliver thalidomide and si-SALL4-B to target SALL4 for inhibiting angiogenesis. A SALL4-B, VEGF-A, B, and C expression levels were detected in MGC-803 cells treated with engineered exosomes (EX-293T, EX-THAL, EX-si-SALL4-B, and EX-THAL + si-SALL4-B) by using real-time RT-PCR. B SALL4-B, VEGF-A, B, and C expression was detected by using a western blot in MGC-803 cells treated with engineered exosomes. C ELISA assay was used to measure VEGF-A, B, and C expression levels in the conditioned medium from MGC-803 cells treated with engineered exosomes. HUVEC cells were in cubated with the conditioned medium from engineered exosomes-treated MGC-803 cells. The proliferation, migration, and angiogenic abilities of HUVEC cells were analyzed by using the CCK-8 assay (D), transwell assay (E), and tube formation assay (F). The results are presented as the means ± standard error of mean (SEM). **P < 0.01, *** P < 0.001
Article Snippet: Co-transfection with
Techniques: Expressing, Quantitative RT-PCR, Western Blot, Enzyme-linked Immunosorbent Assay, Migration, CCK-8 Assay, Transwell Assay, Tube Formation Assay
Journal: Cancer cell international
Article Title: SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression.
doi: 10.1186/s12935-023-02985-9
Figure Lengend Snippet: Fig. 9 Proposed model of SALL4’s role in gastric cancer angiogenesis. SALL4 functions as a transcription factor that binds to VEGF-A, B, and C promoters and activates their expression. Exosomal delivery of si-SALL4-B and thalidomide results in targeted inhibition of SALL4-B and VEGF-A, B, and C expression, leading to suppression of gastric cancer angiogenesis
Article Snippet: Co-transfection with
Techniques: Expressing, Inhibition
Journal: Briefings in Bioinformatics
Article Title: ChIP-AP: an integrated analysis pipeline for unbiased ChIP-seq analysis
doi: 10.1093/bib/bbab537
Figure Lengend Snippet: Union peak set comprehensiveness and accuracy. ( A ) Fingerprint plot for aligned sequence files. Negligible separation between the SALL4 and control curves indicates poor enrichment in the SALL4 samples, an experiment typically considered as having failed. ( B ) Upset plot describing the distribution of peaks observed by each peak caller. The left histogram represents the total number of called peaks per caller. The top histograms represent the size of the sub-sets in question. The connected circles represent highlighted overlap. ( C ) Venn diagram showing the overlapping number of peaks between the SALL4 union ChIP-seq dataset and the Cut&Run dataset, both of which were done on SNU-398 cells. ( D ) The motif sequence used for the directed motif search in the SALL4 ChIP-seq union set, which was found in 55.2% of the union set. ( E ) The STREME de novo motif search for the SALL4 union peak set identified the AT-rich binding motif as the second result. ( F ) The HOMER de novo motif search for the SALL4 union peak set identified the AT-rich binding motif as the third result. ( G ) The STREME identified motif (shown in D ) was found centrally enriched in the union peak set as compared to background sequences; an accepted indicator of a valid motif result. ( H ) Venn diagram depicting the degree of overlap in the number of genes between the SALL4 ChIP-seq union peak set, the SALL4 Cut&Run peak set and the SALL4 KD DEG list.
Article Snippet: Antibody-protein A/G Dynabead conjugate was prepared by adding 0.75 μg of
Techniques: Sequencing, Control, ChIP-sequencing, Binding Assay
Journal: Briefings in Bioinformatics
Article Title: ChIP-AP: an integrated analysis pipeline for unbiased ChIP-seq analysis
doi: 10.1093/bib/bbab537
Figure Lengend Snippet: The SALL4 ChIP-seq was processed with ChIP-AP (v5.1) using hg38. Below is the settings table (ST) used.
Article Snippet: Antibody-protein A/G Dynabead conjugate was prepared by adding 0.75 μg of
Techniques:
Journal: Oncotarget
Article Title: SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinoma
doi:
Figure Lengend Snippet: Association between SALL4 expression and clinicopathologic characteristics in ICC patient
Article Snippet: Briefly,
Techniques: Expressing, Infection
Journal: Oncotarget
Article Title: SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinoma
doi:
Figure Lengend Snippet: Association between the expression of SALL4 and other markers in ICC
Article Snippet: Briefly,
Techniques: Expressing
Journal: Oncotarget
Article Title: SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinoma
doi:
Figure Lengend Snippet: The overall survival curves for SALL4-negative (−) ( n = 73), weak SALL4-positive cases (+) ( n = 49), moderate SALL4-positive cases (++) ( n = 46) and strong SALL4-positive cases (+++) ( n = 7) in ICC
Article Snippet: Briefly,
Techniques:
Journal: Oncotarget
Article Title: SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinoma
doi:
Figure Lengend Snippet: Western blot was conducted to determine the protein level of SALL4 in ICC-9810 cells transfected with SALL4 siRNA or non-specific siRNA as negative control (NC). GAPDH was used as loading control. Non-transfected ICC-9810 cells were used as Control. ** P < 0.01 vs. Control
Article Snippet: Briefly,
Techniques: Western Blot, Transfection, Negative Control, Control
Journal: Oncotarget
Article Title: SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinoma
doi:
Figure Lengend Snippet: MTT assay was conducted to determine the cell proliferating capacity of ICC-9810 cells transfected with SALL4 siRNA or non-specific siRNA as negative control (NC). Non-transfected ICC-9810 cells were used as Control. ** P < 0.01 vs. Control
Article Snippet: Briefly,
Techniques: MTT Assay, Transfection, Negative Control, Control
Journal: Oncotarget
Article Title: SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinoma
doi:
Figure Lengend Snippet: Transwell assay was conducted to determine the cell invasive capacity of ICC-9810 cells transfected with SALL4 siRNA or non-specific siRNA as negative control (NC). Non-transfected ICC-9810 cells were used as Control. ** P < 0.01 vs. Control
Article Snippet: Briefly,
Techniques: Transwell Assay, Transfection, Negative Control, Control
Journal: Oncotarget
Article Title: SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinoma
doi:
Figure Lengend Snippet: Western blot was conducted to determine the protein levels of E-cadherin and N-cadherin in ICC-9810 cells transfected with SALL4 siRNA or non-specific siRNA as negative control (NC). GAPDH was used as loading control. Non-transfected ICC-9810 cells were used as Control. ** P < 0.01 vs. Control
Article Snippet: Briefly,
Techniques: Western Blot, Transfection, Negative Control, Control
Journal: Oncogene
Article Title: SALL4, a novel marker for human gastric carcinogenesis and metastasis.
doi: 10.1038/onc.2013.495
Figure Lengend Snippet: Figure 1. SALL4 expression in gastric cancer tissues and paired adjacent normal tissues. (a) Semi-quantitative RT-PCR analyses of SALL4 mRNA expression in gastric cancer (T) and paired non-cancerous (N) tissues. B, blank; M, DNA Marker (DL-2000). (b) Real-time RT-PCR analyses of SALL4 mRNA levels in gastric cancer (T) and paired non-cancerous (N) tissues. Solid line indicates matched samples. (c) Western blotting assay of SALL4 protein levels in gastric cancer (T) and paired non-cancerous (N) tissues. (d) Immunohistochemical staining of SALL4 in gastric cancer tissues. (1) Cytoplasmic localization; (2) nuclear localization; and (3) cytoplasmic and nuclear localization. Original magnification 400; bar ¼ 50 mm. (e) Representative images of SALL4 staining in surgical specimens from normal, intestinal metaplasia and gastric cancer tissues. (1) Adjacent non-cancerous tissues; (2) intestinal metaplasia; (3) well-differentiated adenocarcinoma; (4) moderately differentiated adenocarcinoma; and (5) poorly differentiated adenocarcinoma. Original magnification, 200; bar ¼ 100 mm.
Article Snippet: Osteogenic and adipogenic differentiation in vitro HGC-27 cells stably expressing
Techniques: Expressing, Quantitative RT-PCR, Marker, Western Blot, Immunohistochemical staining, Staining
Journal: Oncogene
Article Title: SALL4, a novel marker for human gastric carcinogenesis and metastasis.
doi: 10.1038/onc.2013.495
Figure Lengend Snippet: Figure 2. SALL4 expression in human gastric cancer cell lines. (a) Real-time RT-PCR and (b) immunofluorescence analyses of SALL4 expression in AGS, SGC-7901, HGC-27 and MGC80-3 human gastric cancer cells. Original magnification, 400; bar ¼ 50 mm. (c) Transwell migration assay for AGS, SGC-7901, HGC-27 and MGC80-3 human gastric cancer cells. Original magnification, 100; bar ¼ 200 mm.
Article Snippet: Osteogenic and adipogenic differentiation in vitro HGC-27 cells stably expressing
Techniques: Expressing, Quantitative RT-PCR, Transwell Migration Assay
Journal: Oncogene
Article Title: SALL4, a novel marker for human gastric carcinogenesis and metastasis.
doi: 10.1038/onc.2013.495
Figure Lengend Snippet: Figure 3. SALL4 overexpression enhances the proliferation and migration of HGC-27 cells. (a) Real-time RT-PCR analyses of SALL4 expression in stably transfected HGC-27 cells, ***Po0.001. (b) Immunofluorescence analyses of SALL4 expression in stably transfected HGC-27 cells. Original magnification, 200; bar ¼ 100 mm. (c) The growth of vector and SALL4-overexpressing HGC-27 cells was determined by cell counting assay. Data were presented as mean±s.d. of three wells. *Po0.05, compared with the vector cells. (d) Representative images of colony formation in mock and SALL4-overexpressing HGC-27 cells. Original magnification, 40; bar ¼ 500 mm. (e1) The migratory ability of mock and SALL4-overexpressing HGC-27 cells was evaluated by transwell migration assay. Original magnification, 100; bar ¼ 200 mm. (e2) The number of migrated cells in panel (e1) was quantified. ***Po0.001. (f) The expression of ERK, p-ERK, JNK, Bcl-2 and Bax proteins in mock and SALL4-overexpressing HGC-27 cells was examined by western blotting.
Article Snippet: Osteogenic and adipogenic differentiation in vitro HGC-27 cells stably expressing
Techniques: Over Expression, Migration, Quantitative RT-PCR, Expressing, Stable Transfection, Transfection, Plasmid Preparation, Cell Counting, Transwell Migration Assay, Western Blot
Journal: Oncogene
Article Title: SALL4, a novel marker for human gastric carcinogenesis and metastasis.
doi: 10.1038/onc.2013.495
Figure Lengend Snippet: Figure 4. SALL4 silencing reduces the proliferation and migration of SGC-7901 cells. (a) SGC-7901 cells were transfected with distinct SALL4 siRNA (siRNA-1, 2 and 3) or the matching scramble control siRNA. The expression of SALL4 mRNA was analyzed using real-time RT-PCR. (b) SGC-7901 cells were transfected with SALL4 siRNA-2 or the matching scramble control siRNA. The expression of SALL4 protein was analyzed by western blotting. (c1) Representative images of cell colonies in control and SALL4 siRNA-transfected SGC-7901 cells. (c2) Colonies with 4100 cells were quantified. (d1) The migratory ability of control and SALL4 siRNA-transfected SGC-7901 cells was evaluated by using transwell migration assay. (d2) The number of migrated cells was quantified. Original magnification, 100; bar ¼ 200 mm. **Po0.01, ***Po0.001, compared with the mock group.
Article Snippet: Osteogenic and adipogenic differentiation in vitro HGC-27 cells stably expressing
Techniques: Migration, Transfection, Control, Expressing, Quantitative RT-PCR, Western Blot, Transwell Migration Assay
Journal: Oncogene
Article Title: SALL4, a novel marker for human gastric carcinogenesis and metastasis.
doi: 10.1038/onc.2013.495
Figure Lengend Snippet: Figure 5. SALL4 overexpression induces EMT and stemness of HGC-27 cells. (a) The expression of EMT markers in SALL4-overexpressing HGC-27 cells was determined by western blotting. (b) Expression of mesenchymal marker N-cadherin in SALL4-overexpressing HGC-27 cells was examined by immunofluorescence. Original magnification, 200; bar ¼ 100 mm. (c) Western blotting for stemness markers in SALL4-overexpressing HGC-27 cells. (d) HGC-27 cells stably expressing SALL4 were positive for alizarin red after being induced into osteogenic lineage and showed accumulation of lipid droplets after undergoing adipogenic differentiation. Original magnification, 400; bar ¼ 100 mm.
Article Snippet: Osteogenic and adipogenic differentiation in vitro HGC-27 cells stably expressing
Techniques: Over Expression, Expressing, Western Blot, Marker, Stable Transfection
Journal: Oncogene
Article Title: SALL4, a novel marker for human gastric carcinogenesis and metastasis.
doi: 10.1038/onc.2013.495
Figure Lengend Snippet: Figure 6. SALL4 overexpression promotes tumorigenesis and metastasis in vivo. Representative images of tumor-bearing mice (a), tumor incidence (b), tumor growth curves (c) and tumor weight (d) was evaluated in mice transplanted with mock and SALL4-overexpressing HGC- 27 cells. (e) Real-time RT-PCR analyses of E-cadherin and N-cadherin mRNA expression in xenograft tumors. ***Po0.001. (f1) Macroscopic appearance of the peritoneal disseminations. Peritoneal dissemination was recognized from the innumerable tumor nodules visualized in the abdominal cavity, mesenterium and omentum. Arrows in the pictures indicate tumors developing peritoneal metastasis or invading the respective organs. (f2) Histological images of tumor in the liver (up) and abdominal cavity (down) of mouse intraperitoneally injected with SALL4-overexpressing HGC-27 cells (1 107). Original magnification, 400; bar ¼ 100 mm.
Article Snippet: Osteogenic and adipogenic differentiation in vitro HGC-27 cells stably expressing
Techniques: Over Expression, In Vivo, Quantitative RT-PCR, Expressing, Injection
Journal: World Journal of Surgical Oncology
Article Title: Clinicopathological and prognostic significance of SWI/SNF complex subunits in undifferentiated gastric carcinoma
doi: 10.1186/s12957-022-02847-0
Figure Lengend Snippet: Summary of antibody information
Article Snippet:
Techniques:
Journal: World Journal of Surgical Oncology
Article Title: Clinicopathological and prognostic significance of SWI/SNF complex subunits in undifferentiated gastric carcinoma
doi: 10.1186/s12957-022-02847-0
Figure Lengend Snippet: Immunohistochemistry results of 21 cases with undifferentiated/dedifferentiated gastric carcinoma
Article Snippet:
Techniques: Immunohistochemistry